0001213900-13-003266.txt : 20130624 0001213900-13-003266.hdr.sgml : 20130624 20130624192001 ACCESSION NUMBER: 0001213900-13-003266 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130620 FILED AS OF DATE: 20130624 DATE AS OF CHANGE: 20130624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZELDIS JEROME B CENTRAL INDEX KEY: 0001433982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 13930601 MAIL ADDRESS: STREET 1: 8767 E. VIA DE VENTURA, SUITE 190 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 4 1 f4062013zeldis_soligenix.xml X0306 4 2013-06-20 0 0000812796 SOLIGENIX, INC. SNGX 0001433982 ZELDIS JEROME B 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 1 0 0 0 Common Stock 2013-06-20 4 M 0 25000 0.30 A 25000 D Stock Option (Right to Buy) 0.30 2013-06-20 4 M 0 25000 0 D 2022-06-20 Common Stock 25000 0 D The option vested in installments of 6,250 shares on each of September 21, 2012, December 21, 2012, March 21, 2012 and June 21, 2012. /s/ Jerome B. Zeldis 2013-06-24